Close

Goldman Sachs Starts TherapeuticsMD (TXMD) at Buy

April 4, 2016 6:35 AM EDT
Get Alerts TXMD Hot Sheet
Price: $2.26 +0.44%

Rating Summary:
    10 Buy, 4 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 10
Join SI Premium – FREE

Goldman Sachs initiated coverage on TherapeuticsMD (NYSE: TXMD) with a Buy rating and a price target of $10.00.

For an analyst ratings summary and ratings history on TherapeuticsMD click here. For more ratings news on TherapeuticsMD click here.

Shares of TherapeuticsMD closed at $6.62 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage

Related Entities

Goldman Sachs